AUS
NZ
UK
CA
USA
IND
Healthcare
Arcellx Inc (NASDAQ:ACLX) Nasdaq Index Biotech Momentum
December 08, 2025 12:00 AM PST| By Anmol KhazanchiArcellx (NASDAQ:ACLX) drives next-generation immunotherapy through engineered cellular platforms, frequently appearing in biotechnology discussions shaped by the nasdaq index and evolving clinical-science models.
Novo Nordisk (NYSE:NVO) Extends Medical Impact Across Global Markets
December 08, 2025 12:00 AM PST| By Anmol KhazanchiNovo Nordisk A/S expands its global therapeutic impact through advanced research, regulated manufacturing, and broad distribution networks supporting chronic and rare disease care across multiple international regions.
Disc Medicine (NASDAQ:IRON) Builds Momentum In Clinical Science
December 08, 2025 12:00 AM PST| By Anmol KhazanchiDisc Medicine advances therapeutic programs focused on hematologic pathways and red-cell regulation, reinforcing its role in clinical research through specialised development efforts and expanding scientific relevance.
ALX Oncology (Nasdaq:ALXO) Reports High Response Rates for Evorpacept Combo in Indolent B-cell NHL at ASH 2025
December 07, 2025 09:16 PM PST| By Team Kalkine MediaHighlights,The combination of evorpacept with rituximab and lenalidomide achieved complete responses in 92% of untreated indolent non-Hodgkin lymphoma patients, well above the historically observed rate of around 50% for R2 alone.,The study showed th...
CONMED (NYSE:CNMD) Strengthens Global Surgical Technology Reach
December 07, 2025 12:00 AM PST| By Anmol KhazanchiCONMED Corporation strengthens its medical presence through orthopedic technologies, minimally invasive surgical systems, and global clinical support programs that enhance procedural precision across healthcare environments.
Fortrea Holdings (NASDAQ:FTRE) NASDAQ Index Fund Biopharma Power
December 06, 2025 12:00 AM PST| By Anmol KhazanchiFortrea (NASDAQ:FTRE) plays a pivotal role in biopharmaceutical and medical device development, contributing to the growing sector presence within the nasdaq index fund, where innovation in healthcare is central.
iRhythm Technologies (NASDAQ:IRTC) Nasdaq Index Data-Driven Health Solutions
December 06, 2025 12:00 AM PST| By Anmol KhazanchiiRhythm Technologies (NASDAQ:IRTC) drives innovation in cardiac monitoring, leveraging digital solutions for healthcare, aligning with trends in the nasdaq index as it shapes the future of patient care.
Lantheus Holdings (NASDAQ:LNTH) Nasdaq Today Healthcare Disruptor
December 06, 2025 12:00 AM PST| By Anmol KhazanchiLantheus Holdings (NASDAQ:LNTH) drives innovations in cardiovascular and oncology imaging, contributing to advancements in healthcare solutions and aligning with trends in nasdaq today, where biotech leaders thrive.
Soleno Therapeutics (NASDAQ:SLNO) Nasdaq Index Clinical Pipeline Growth
December 06, 2025 12:00 AM PST| By Anmol KhazanchiSoleno Therapeutics (NASDAQ:SLNO) leads in rare disease treatments, focusing on conditions like Prader-Willi Syndrome. Its research and clinical trials place it within the broader conversations surrounding the Nasdaq index.
Merck (NYSE:MRK) S&P 500 Companies Power Drug Progress
December 06, 2025 12:00 AM PST| By Anmol KhazanchiMerck (NYSE:MRK) advances pharmaceutical, vaccine, biologics, and animal health programs, maintaining strong visibility among s&p 500 companies through its global medical capabilities and multi-segment operations.
Haemonetics Corporation (NYSE:HAE) Enhances Medical Innovation
December 06, 2025 12:00 AM PST| By Anmol KhazanchiHaemonetics Corporation strengthens its role in medical technology through automated collection devices, digital platforms, and global expansion, supporting efficient clinical operations across healthcare environments.
Humana (NYSE:HUM) Shares Steady Amid Dividend Theme Focus Update
December 05, 2025 06:39 AM PST| By Anmol KhazanchiArticle exploring Humana’s placement within the healthcare coverage sector, highlighting dividend themes, operational continuity, and broader structural characteristics of the field.
Explore Eli Lilly Developments Across the Pharmaceutical Landscape
December 05, 2025 01:57 AM PST| By Team Kalkine MediaHighlights,Pharmaceutical research activity continues to shape therapeutic development across metabolic health segments.,Product portfolios addressing chronic conditions remain central to large drug manufacturers.,Regulatory review processes play a d...
Health Insurance Sector Overview and Industry Structure Explained
December 05, 2025 12:21 AM PST| By Team Kalkine MediaHighlights,Health insurance forms a core component of the healthcare services ecosystem in the United States.,Large insurers operate across medical coverage, pharmacy services, and care coordination activities.,Regulatory frameworks and demographic p...
AbCellera Biologics (NASDAQ:ABCL) Nasdaq Today Biotech Pioneer
December 05, 2025 12:00 AM PST| By Anmol KhazanchiAbCellera Biologics (NASDAQ:ABCL) leads antibody drug discovery, shaping biopharmaceutical development and aligning with technological advancements tracked by nasdaq today in the biotech sector.
Savara (NASDAQ:SVRA) Nasdaq Today Specialized Biotech Direction
December 04, 2025 12:00 AM PST| By Anmol KhazanchiSavara (NASDAQ:SVRA) strengthens its biotechnology role through rare-disease respiratory programs, specialised development work, and sector relevance shaped by nasdaq today.
CRISPR Therapeutics (NASDAQ:CRSP) Nasdaq Index Biotech Momentum
December 04, 2025 12:00 AM PST| By Anmol KhazanchiCRISPR Therapeutics (NASDAQ:CRSP) remains central to biotechnology coverage as gene-editing developments and institutional activity draw attention across the Nasdaq Index.
Vir Biotechnology (NASDAQ:VIR) Nasdaq Index Fund Health Drive
December 04, 2025 12:00 AM PST| By Team Kalkine MediaVir Biotechnology (NASDAQ:VIR) strengthens global healthcare by advancing treatments for infectious diseases while maintaining prominence in Nasdaq Index Fund trends.
PTC Therapeutics (NASDAQ:PTCT) NASDAQ Index Impact In Healthcare
December 04, 2025 12:00 AM PST| By Anmol KhazanchiPTC Therapeutics (NASDAQ:PTCT) influences the biotechnology sector through rare disease treatments, making a significant impact on Nasdaq Index discussions.
Abivax (NASDAQ:ABVX) Navigates Biotechnology Challenges In Clinical Stage
December 04, 2025 12:00 AM PST| By Anmol KhazanchiAbivax focuses on immune modulation to treat chronic inflammatory diseases, with its lead candidate obefazimod in Phase 3 trials for ulcerative colitis.
